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Abstract
Background: Despite a greater burden of risk factors, atrial fibrillation (AF) is less common among African Americans than
European-descent populations. Genome-wide association studies (GWAS) for AF in European-descent populations have
identified three predominant genomic regions associated with increased risk (1q21, 4q25, and 16q22). The contribution of
these loci to AF risk in African American is unknown.
Methodology/Principal Findings: We studied 73 African Americans with AF from the Vanderbilt-Meharry AF registry and 71
African American controls, with no history of AF including after cardiac surgery. Tests of association were performed for 148
SNPs across the three regions associated with AF, and 22 SNPs were significantly associated with AF (P,0.05). The SNPs with
the strongest associations in African Americans were both different from the index SNPs identified in European-descent
populations and independent from the index European-descent population SNPs (r
2,0.40 in HapMap CEU): 1q21 rs4845396
(odds ratio [OR] 0.30, 95% confidence interval [CI] 0.13–0.67, P=0.003), 4q25 rs4631108 (OR 3.43, 95% CI 1.59–7.42,
P=0.002), and 16q22 rs16971547 (OR 8.1, 95% CI 1.46–45.4, P=0.016). Estimates of European ancestry were similar among
cases (23.6%) and controls (23.8%). Accordingly, the probability of having two copies of the European derived
chromosomes at each region did not differ between cases and controls.
Conclusions/Significance: Variable European admixture at known AF loci does not explain decreased AF susceptibility in
African Americans. These data support the role of 1q21, 4q25, and 16q22 variants in AF risk for African Americans, although
the index SNPs differ from those identified in European-descent populations.
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Introduction
Atrial fibrillation (AF) is the most frequent arrhythmia in clinical
practice, with over 2.3 million Americans diagnosed with the
disease [1]). The incidence of AF varies by race, occurring more
frequently in European Americans than in African Americans
[2,3]. Paradoxically, risk factors for AF including hypertension
(HTN), obesity, diabetes mellitus (DM), and congestive heart
failure (CHF) are more prevalent in African Americans [3–7]. As a
result, traditional risk factors used to assess AF risk among African
Americans perform poorly in this population.
Over the last few years, several genetic variants have been
associated with AF risk in genome-wide association studies
(GWAS) performed in populations of European-descent [8]. To
date, three genomic regions/candidate genes have been identified:
4q25 near PITX2,i nZFHX3 on 16q22, and in KCNN3 on 1q21
[9–12]. For the 4q25 locus, rs2200733 has been consistently the
SNP with the highest risk in multiple GWAS cohorts and in a fine
mapping study of the region [13]. The 4q25 locus also includes
other SNPs that predict risk and are not in linkage disequilibrium
with rs2200733 [13]. For both ZFHX3 and KCNN3, the reported
index SNP has varied among studies likely reflecting the strong
linkage disequilibrium observed for these genomic regions in
European-descent populations [9–14]. As no GWAS has yet been
performed for AF in populations of African-descent, it remains to
be determined whether there is an association with these regions
and if there is, whether the index European variants from these
three genomic regions generalize to African Americans or if there
are additional variants in the same genomic regions more strongly
associated with AF in populations of non-European-descent.
African-descent populations such as African Americans are
often used for fine-mapping experiments based on the different
allelic architecture and lower levels of linkage disequilibrium of
these populations compared with European Americans [15].
African Americans, however, are also a genetically heterogeneous
population, with varying European and African contributions. It is
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the risk of AF [16–18]. Indeed, genetic ancestry has been
associated with disease risk for many diseases including obesity,
hypertension (HTN), diabetes mellitus (DM), kidney disease,
asthma, rheumatoid arthritis, breast cancer, and prostate cancer
[19–29]. Recently, the proportion of European ancestry in African
Americans was associated with the development of AF in
individuals enrolled in the Cardiovascular Health Study (CHS)
and Atherosclerosis Risk in Communities (ARIC) Study [30].
We report here a targeted genetic association study of AF in
African Americans ascertained at Vanderbilt University in Nash-
ville, TN. We first sought to generalize in African Americans three
regions associated with AF risk in European-descent populations.
We then calculated estimates of genetic ancestry and tested for
associationswithAFinAfrican Americans.We demonstrate that for
the three regions discovered in European-descent populations do
generalize with respect to direction of effect, although the best index
genetic variant associated with AF in African Americans is different.
Our data also suggest that in contrast to previous reports based on
genome-wide data, AF is not associated with admixture in this
dataset for these three genomic regions.
Methods
Ethics Statement
The study protocol was approved by the Vanderbilt University
Institutional Review Board. A written informed consent was
obtained from all patients prior to enrollment.
Study Population
Cases were selected from patients consecutively enrolled in the
Vanderbilt-Meharry AF registry who self-reported African Amer-
ican race. Details of the Vanderbilt-Meharry AF registry have
been previously published [31]. In brief, from 2002 to present, the
registry has been prospectively enrolling patients with newly
diagnosed AF or a documented history of AF, excluding those who
developed atrial fibrillation in the post-operative period after
cardiac surgery. Clinical data and blood samples were obtained at
the time of enrollment.
Controls were selected from the Vanderbilt Cardiac Surgery
registry, a registry of consecutive patients undergoing cardiac
surgery [32]. Controls were selected among those who did not
develop AF in the post-operative period from cardiac surgery and
self-reported African American ancestry. Patients with a personal or
family history of AF were excluded. The study protocol was
approved by the Vanderbilt University Institutional Review Board,
and participants wereenrolled after informed consentwas obtained.
SNP selection
We selected SNPs based on three index associations observed in
European-descent populations for AF. The three index SNPs
include rs2200733, an intergenic SNP located at 4q25 near
PITX2; rs13376333, an intronic SNP located at 1q21 in KCNN3;
and rs2106261 an intronic SNP located at 16q22 in ZFX [9–12].
Regions of interest from the index SNP were identified in African
American samples from the southwest (ASW) in the International
HapMap Project using the Genome Variation Server (http://gvs.
gs.washington.edu/GVS/). We implemented LDSelect to identify
tagSNPs in the three regions of interest for genotyping [33]. In
brief, all SNPs in the region were filtered by minor allele frequency
(MAF 5%) in the ASW sample. Common SNPs were then binned
by linkage disequilibrium (r
2) for each of the three regions based
on the ASW data. A tagSNP was selected from each bin with the
criteria that the tagSNP was in strong LD with the other SNPs in
the bin (r
2 threshold of 0.80) but independent (i.e. not in strong
LD) with other tagSNPs across bins. If multiple tagSNPs were
available per bin, priority was given to the tagSNP identified in
prior European descent AF GWAS studies followed by those with
the highest PhastCons Conservation Score. A total of 51 tagSNPs
around rs1337633, 50 tagSNPs around rs2200733, and 47
tagSNPs around rs2106261 were included for genotyping. Due
to varying linkage disequilibrium, the genomic distance covered by
selected tagSNPs varied: 400 kb for rs2200733, 200 kb for
rs13376333, and 160 kb for rs2106261.
SNP Genotyping
Genotyping was performed by the Vanderbilt DNA Resources
Core with either Sequenom iPLEX GoldH assay on the
MassARRAYH Platform or Applied Biosystem’s TaqMan. All
SNP call rates were .95%, with an average call rate of 99%.
Three samples were excluded from the analysis due to low
genotyping efficiency (,95%). Tests of Hardy-Weinberg equilib-
rium (HWE) were calculated separately for cases and controls, and
no SNP deviated from HWE (p,0.0003).
Statistical Methods
Differences between cases and controls were identified using a
chi-square test or a Student’s t-test for variables listed in Table 1.
Using logistic regression implemented in PLINK [34], tests of
association were performed both unadjusted and adjusted for age,
body mass index (BMI), prevalent congestive heart failure (CHF),
prevalent diabetes mellitus (DM), prevalent HTN, and prevalent
coronary artery disease (CAD) assuming an additive genetic model
for all SNPs that passed quality control described above (148
SNPs). All adjusted tests of association are shown in Table S1.
Comparison of the allele frequencies for the ten most significantly
associated SNPs of cases and controls to HapMap Phase II CEU
and West African (YRI) samples was performed with chi-square
test. The fixation index FST, a measure of population differenti-
ation, was calculated using the Weir and Cockerham algorithm
[35] implemented in the Platform for the Analysis, Translation,
and Organization of large-scale data (PLATO) [36]. Correction
for multiple comparisons by permutation testing and calculation of
the False Discovery Rate (FDR) was performed in (PLINK) [34].
Table 1. Study Population Characteristics.
Trait Case (n=73) Control (n=71) p-value
Age, y 50.261.7 53.761.5 0.06
Gender, %female 42.4 56.3 0.09
Body Mass Index, kg/m
2 35.161.1 28.860.8 ,0.001
Left Atrial Size 44.461.5 42.461.3 0.58
Left Ventricular Ejection Fraction, % 46.462.1 46.361.7 0.19
Hypertension, % 84.9 84.5 0.94
Diabetes, % 26 35.2 0.23
Congestive heart failure, % 40.9 25.4 0.05
Stroke, % 19.1 17.9 0.89
Coronary artery disease, % 26.8 71.4 ,0.001
Current smoker, % 19.4 31.4 0.11
% European Ancestry 23.6 23.8 0.64
Mean (6 standard errors) or proportions are given for each variable among
cases and controls. A chi-square test or a Student’s t-test was performed to test
for differences between cases and controls, where appropriate.
doi:10.1371/journal.pone.0032338.t001
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percent European ancestry within the three loci was calculated
and averaged over all independent SNPs (r
2,0.8) using ANCES-
TRYMAP [37]. In addition, local estimates of European ancestry
were calculated using HAPMIX [38]. This method determines the
likelihood that a haplotype from an admixed individual is derived
from one reference population using phased haplotype informa-
tion from the International HapMap Project. For our African
American samples, we used phased haplotype data from CEU and
YRI HapMap Phase II. We calculated the probability for each
individual having 0, 1, or 2 copies of a European allele at each
locus. For each individual, we averaged the number of copies of
European alleles over all SNPs for each chromosome separately.
Logistic regressions with AF case-control status as the dependent
variable and estimates of European ancestry as the independent
variable were performed. Logistic regression with adjustment for
ancestry in addition to the covariates discussed above was also
performed for all SNPs.
Using Quanto we calculated our power to detect GWAS-
identified associations in our African American study population
[39,40]. We assumed the reported effect size (OR) in Europeans to
calculate the power to detect this effect given our sample size and
minor allele frequencies in African Americans.
Results
Study Population
Of the 1,624 patients enrolled in the Vanderbilt-Meharry AF
registry, 73 were self-identified as African American. From the
Vanderbilt Cardiac Surgery registry, 71 controls were identified
for comparison. Cases and controls did not differ with respect to
mean age or proportion of females (Table 1). Cases had a higher
mean body mass index (BMI; 35.1 kg/m
2) and higher prevalence
of CHF (40.9%) compared with controls (28.8 kg/m
2 and 25.4%,
respectively, p,0.001; Table 1). Controls had an increased
prevalence of CAD compared with cases (71.4% versus 26.8%,
p,0.001), which is consistent with their selection from a post-
operative cardiac surgery registry.
Association results
A total of 22/148 SNPs were associated with AF in adjusted
models at P,0.05 (Table 2). Further adjustment for European
ancestry did not appreciably alter the results (data not shown). The
greatest proportion of significant associations among tested SNPs
was observed in the region of 4q25 (15/50; 30%), followed by
1q21 (6/51; 11.8%), and 16q22 (1/47; 2.1%). The most significant
SNP in each region in this African American dataset differed from
the index SNPs from previously published European-descent
populations: rs4631108 (4q25), rs16971547 (1q21), and rs4845396
(16q22) (Figures S1,S2,S3). Similar to the index SNPs identified in
European Americans, the African American index SNPs were
either intergenic (rs4631108) or intronic (rs16971547 and
rs4845396).
Of the three European-descent index SNPs, both rs2200733
and rs1337633 were significantly associated with AF among
African Americans, while rs2106261 was not. Regardless of
significance, the direction of effect for all three index SNPs in
African Americans was consistent with that previously reported for
Table 2. SNPs associated with atrial fibrillation in African Americans.
SNP CHR Chromosomal Location Coded Allele OR 95% Confidence Interval P-value
rs4631108 4 111773867 A 3.430 1.587–7.417 0.002
rs4845396 1 154828409 A 0.298 0.134–0.663 0.003
rs2200733 4 111929618 T 3.283 1.495–7.207 0.003
rs1906602 4 111713323 C 5.926 1.795–19.570 0.004
rs4845397 1 154832304 C 0.321 0.147–0.699 0.004
rs2634071 4 111669220 A 2.810 1.353–5.836 0.006
rs4605724 4 111685081 A 4.723 1.535–14.530 0.007
rs2723334 4 111688752 G 0.376 0.183–0.774 0.008
rs6843082 4 111718067 G 2.629 1.284–5.383 0.008
rs12647316 4 111649251 T 3.760 1.399–10.100 0.009
rs10516563 4 111677722 G 3.283 1.332–8.097 0.010
rs11264275 1 154825270 G 0.385 0.181–0.820 0.013
rs4277843 4 111777749 G 2.280 1.173–4.434 0.015
rs6426987 1 154815257 C 0.454 0.240–0.861 0.016
rs16971547 16 73075708 C 8.162 1.467–45.420 0.016
rs6838973 4 111765495 T 0.365 0.157–0.852 0.019
rs13376333 1 154814353 T 2.292 1.124–4.672 0.022
rs4285153 4 111778733 A 0.506 0.265–0.966 0.039
rs11098092 4 111798201 A 2.143 1.037–4.432 0.040
rs3866823 4 111782436 T 2.281 1.033–5.040 0.041
rs11930528 4 111660194 T 2.103 1.025–4.315 0.043
rs1984285 1 154796895 G 0.287 0.083–0.988 0.048
SNP, location (NCBI.36), coded allele, odds ratios, 95% confidence intervals, and p-value are shown for significant associations (p,0.05) after adjusting for age, BMI,
history of CAD, history of CHF, history of diabetes, and history of hypertension.
doi:10.1371/journal.pone.0032338.t002
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SNPs, three additional SNPs also previously reported to be
strongly associated with AF within the selected region were
evaluated: rs10033464, rs6843082, and rs7193343. Only
rs6843082 was significantly associated in this African American
sample. Again, regardless of significance, all three of these SNPs
maintained a consistent direction of effect compared with
European-descent populations (Figure 1).
Genetic Ancestry
Given that African Americans have a greater risk for AF but the
incidence is lower compared with European Americans, we tested
the hypothesis that genomic regions associated with AF in African
Americans would have a higher percentage of European ancestry
compared with genome-wide averages [2,3]. This was tested using
two strategies. First, we calculated FST between CEU and case
samples, and we compared minor allele frequencies in cases and
controls to HapMap CEU and YRI samples for the ten most
significant SNPs (Table S2). Case allele frequencies differed from
CEU allele frequencies for all ten SNPs (100%), while only 40%
(4/10) differed in comparison to YRI. For the controls, 50% (5/
10) of SNPs had different allele frequencies when compared to
CEU, while 60% (6/10) differed when compared to YRI. FST
estimates did not reveal major differences between cases and CEU
reference samples (Table S2).
Second, we estimated admixture in cases and controls using
ANCESTRYMAP and HAPMIX, respectively, and tested these
estimates for an association with AF. Estimates of admixture from
ANCESTRYMAP did not differ between cases and controls
(23.6% and 23.8%, respectively; Table 1), and thus did not predict
case-control status in this dataset. Local estimates of European
ancestry for all three regions were calculated using HAPMIX. For
chromosome 1, on average, only 2% of cases had two copies of the
European derived chromosome in this region while no controls
had two copies. On chromosome 4, 50% of cases had two copies
of the European chromosomes at this region compared to 53% of
controls. On chromosome 16, ,2% of cases and controls had two
copies of the European derived chromosome. Based on two
estimates of admixture, cases and controls did not differ in
proportion of European ancestry at any of the loci tested.
Discussion
We demonstrate here that the European index SNPs from three
genomics regions associated with AF are not the index SNPs
associated with AF in African Americans. Using two estimates of
admixture, we also show that European admixture at any of the
genomic regions tested is not associated with increased AF risk in
this African American cohort. Our results suggest that AF remains
a complex genetic disease as the discordant findings of lower
disease prevalence in African Americans, despite the greater
incidence of AF clinical risk factors, cannot be explained by
European admixture within the 1q21, 4q25, and 16q22 regions.
Of the six SNPs previously reported to be strongly associated
with AF in GWA studies of European-descent populations, only
three were found to be associated in African Americans, and their
effect was reduced in comparison to other SNPS within the regions
of interest. SNP rs2200733 in the 4q25 region has consistently
replicated in European American populations as the index SNP,
whereas in our African American cohort, rs4631108 was found to
have the strongest association. A recent fine mapping study of the
4q25 region in European-descent populations identified two
additional tagSNPs with a strong association with AF [13]. Of
these two SNPs, one (rs3853445) was included in our SNP
selection. In adjusted analyses, this SNP was not associated with
AF in African Americans (P=0.164; Table S1). Similar to the
4q25 region, the index SNP observed in African Americans
differed from that reported in European-descent populations for
both 1q21 and 16q22 genomic regions.
Figure 1. A comparison of previously identified significant SNPs from literature to African Americans from Vanderbilt AF cohort.
The case/control sample size for the previously published studies are: Ellinor et. al n=14,179 (11); Kaab et. al. n=36,196 (9); Benjamin et. al. n=46,736
(10); and Gudbjartsson et al. n=39,014 (50). AA= Subjects with self-reported African American race.
doi:10.1371/journal.pone.0032338.g001
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intergenic regions, both of which are often thought of as regions
without obvious function. However, variants in these regions may
modify regulatory elements, ultimately resulting in disturbed
protein expression. The nearest gene target for the intergenic
SNPs found in the 4q25 region is PITX2, a gene believed to be
involved in cardiac development, specifically sinus node develop-
ment and susceptibility to atrial arrhythmias [41,42]. The 1q21
loci is intronic to KCNN3, a gene encoding a voltage-independent
calcium-activated potassium channel, which has been found in a
rabbit model to modify the action potential duration of atrial tissue
resulting in increased AF susceptibility, yet, the contribution of this
channel to repolarization in humans is unknown [43]. The SNPs
located at 16q22 are intronic for ZFHX3, a transcription factor
with unknown cardiac involvement. It has been hypothesized that
ZFHX3 may be a regulatory factor for the JAK/STAT signaling
cascade and this cascade may be involved in atrial fibrillation
susceptibility; however, further study is needed to clarify this
relationship [44,45].
Fine mapping in African Americans has been proposed and
employed to further refine signals from GWAS in European-
descent populations with the premise that the lower levels of LD in
the former population will be more likely to reveal the true casual
SNP in a region of high LD observed in the latter population [46].
Also, the differences in allelic architecture known for these
ancestral populations may reveal additional risk SNPs monomor-
phic or rare in one population but common in another. In this
study, we attempted to capitalize on the lower levels of LD in
African Americans compared with European Americans by
densely genotyping independent SNPs for these three AF-
associated regions. Previous studies of breast cancer and lipid
traits have already capitalized on the differences in LD patterns,
and, like this study, have identified new index SNPs in African
Americans [47,48]. Future studies incorporating new variation
data from the 1000 Genomes Project [49] promise to identify the
full spectrum of ‘‘risk’’ variants for AF and other traits in these
cross-population fine-mapping experiments.
Unlike a previous report in the literature [30], European
ancestry was not associated with increased AF risk in our African
American cohort. Marcus et. al. genotyped 1,747 ancestry
informative markers across the genome from the Illumina custom
ITMAT-Broad-CARe array, while our study focused on 148 SNPs
in three genomic regions previously identified in GWAS. The
conflicting results may be due to the different study designs, such
as the choice of markers (AIMs versus region specific). Also, the
study by Marcus et. al. was larger in sample size compared with
the present study.
The primary limitation of this study is the small sample size,
which is a reflection of the observed reduced prevalence of AF
among African Americans compared with European Americans.
Assuming the European genetic effect size and the African
American MAF, we were powered (.80%) to replicate two of the
three index SNPs from prior GWA studies (rs13376333 and
rs2200733). For the 145 non-index SNPs, we were underpowered
to detect an effect size of ,2.0 to 3.3 (dependent on MAF) at a
liberal p-value threshold of 0.05. The power calculations presented
here should be interpreted with caution given that the European
genetic effect size was assumed to be equal to the African
American effect size for the same variant, the latter of which there
are no available data.
The limited sample size of the present study is also represented
in the confidence intervals, which are wide. ZFX3 rs16971547, for
example, was associated with AF with an odds ratio of 8.162 but
with an upper bound 95% confidence interval of 45.420
(p=0.016). This variant is monomorphic in HapMap CEU but
common in YRI (6%) and ASW (9%). Because of the limited case
count and the low minor allele frequency (5%), the association
identified between rs16971547 and AF in African Americans
would benefit from further study.
Overall, the p-values presented here and in supplementary
material were not corrected for multiple testing. Correction for
multiple testing is complicated given that a fraction of the SNPs
represented replication (that is, the index SNPs) while the others
represented novel tests of association. Also, several methods for
correction are available, each with limitations. For example, the
Bonferroni correction is the most widely implemented method but
it is often criticized for being overly conservative for datasets with
even low levels of linkage disequilibrium between SNPs. Other
methods of correction include the false discovery rate (FDR) and
permutation testing [50]. None of the tests of association reported
here survive correction for multiple testing when either Bonferroni
or FDR are applied (data not shown). However, all SNPs except
rs3866823 with an uncorrected p-value,0.05 have an emphirical
p-value,0.05 after permutation testing. Replication of the
associations reported here in an independent dataset is warranted
given the small sample sizes and variability observed when
implementing various corrections for multiple testing.
In conclusion, despite the overall limited power our study
strongly suggests that the 1q21, 4q25, and 16q22 regions remain
important in assessing AF risk among both European- and
African-descent populations. These data also suggest the under-
lying biology identified by GWAS in European populations also
applies to African American subjects.
Supporting Information
Figure S1 Locus Zoom plot for 1q21 region on chromo-
some 1. Tests of association were performed for each SNP
adjusted for age, body mass index, coronary artery disease,
congestive heart failure, diabetes mellitus, and hypertension and
are represented as circles or a diamond in the figure. SNPs are
plotted based on chromosomal location (x-axis) and significance
level (y-axis). Recombination rates are given on the opposing y-
axis. The index association (rs484596) is denoted by the diamond.
For this region, both the recombination rates, represented by the
right axis, and linkage disequilibrium (based on HapMap phase II
YRI), represented by the dot color in the SNP positions, are low.
(TIF)
Figure S2 Locus Zoom plot for 4q25 region on chromo-
some 4. Tests of association were performed for each SNP
adjusted for age, body mass index, coronary artery disease,
congestive heart failure, diabetes mellitus, and hypertension and
are represented as circles or a diamond in the figure. SNPs are
plotted based on chromosomal location (x-axis) and significance
level (y-axis). Recombination rates are given on the opposing y-
axis. The index association (rs4631108) is denoted by the
diamond. For this region, both the recombination rates,
represented by the right axis, and linkage disequilibrium (based
on HapMap phase II YRI), represented by the dot color in the
SNP positions, are low.
(TIF)
Figure S3 Locus Zoom plot for 16q22 region on
chromosome 16. Tests of association were performed for each
SNP adjusted for age, body mass index, coronary artery disease,
congestive heart failure, diabetes mellitus, and hypertension and
are represented as circles or a diamond in the figure. SNPs are
plotted based on chromosomal location (x-axis) and significance
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axis. The index association (rs16971547) is denoted by the
diamond. For this region, both the recombination.
(TIF)
Table S1 Tests of association for atrial fibrillation in
African Americans. All tests of association are shown here
regardless of significance, adjusted for age, body mass index,
coronary artery disease, congestive heart failure, diabetes mellitus,
and hypertension.
(DOC)
Table S2 Comparison of allele frequencies between
cases and controls and reference samples. Coded allele
frequencies for the ten most significant SNPs are shown for cases,
controls, HapMap CEU, and HapMap YRI samples. Allelic
frequency comparisons were performed with chi-square test and F-
statistic (FST).
(DOCX)
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